Next Article in Journal
siRNA Genome Screening Approaches to Therapeutic Drug Repositioning
Previous Article in Journal
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
Previous Article in Special Issue
Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease
Pharmaceuticals 2013, 6(1), 108-123; doi:10.3390/ph6010108

Notes on Article Versions

NoteDate
Article Published18 January 2013 09:23 CET
article pdf uploaded.18 January 2013 09:30 CET
article word file uploaded.18 January 2013 09:31 CET
article files uploaded.18 January 2013 09:31 CET
article files uploaded.18 January 2013 09:31 CET
article files uploaded.18 January 2013 09:31 CET
article files uploaded.18 January 2013 09:31 CET
article pdf uploaded.21 January 2013 14:40 CET
article xml uploaded.21 January 2013 14:40 CET
article html file updated21 January 2013 14:40 CET
article word file uploaded.21 January 2013 14:41 CET
article html file updated24 January 2013 12:28 CET
article html file updated7 February 2013 17:53 CET
article html file updated8 February 2013 09:33 CET
Article Edited22 February 2013 09:17 CET
article xml file uploaded13 September 2013 17:16 CEST
article html file updated13 September 2013 17:17 CEST
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert